Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Chemed's revenue growth reaccelerated to 10.6% year-over-year in Q3 2026, up from a 1.6% trough in Q1 2026, with gross margins recovering to 33.7% from a 28.9% low in Q3 2025, suggesting the mid-2025 deceleration proved transitory as SG&A leverage improved from roughly 16.7% to 16.1% of revenue.
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Revenue growth reaccelerated to 10.6% year-over-year in Q3 2026 with gross margin recovering to 33.7% from a 28.9% trough, though margins remain 290 basis points below the 36.6% Q4 2024 peak as labor costs and reimbursement mix continue to pressure profitability.
Chemed Corporation has a durable earnings profile, which is a key driver of its bullish investment case.
The company benefits from volatility-driven share repurchases, enhancing shareholder value.
Chemed Corporation demonstrates disciplined capital allocation, contributing to its strong financial performance.
Trailing total returns as of 11/18/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Oct 27, 2026 | $6.75+4.8% vs $6.44 | $691M+0.9% vs $685M |
Q3 2026 Jul 28, 2026 | $6.06+8.2% vs $5.60 | $673M+1.2% vs $665M |
Q2 2026 Apr 23, 2026 | $5.65+6.6% vs $5.30 | $658M+1.2% vs $650M |
Q1 2026 Feb 25, 2026 | $6.42-8.5% vs $7.02 | $639M-3.0% vs $659M |
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Chemed Corporation (CHE) Presents at 2026 UBS Global Healthcare Conference Transcript
CINCINNATI, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 70-cents per share on the Company's capital stock, payable on December 4, 2026, to shareholders of record as of November 16, 2026. This is equal to the dividend paid in September 2026.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Benchmark CHE against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Chemed Corporation (CHE)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $546.75 | $7.26B | 25.43 | 4.06% | 10.61% | 32.1% | 0.4% | |
| $121.56 | $2.27B | 20.33 | 23.21% | 7.39% | 9.81% | — | |
| $186.02 | $10.84B | 27.64 | 18.72% | 7.03% | 16.61% | 0.13% | |
| $73.45 | $10.15B | 15.46 | 2.93% | 14.76% | 41.16% | 1.75% | |
| $28.54 | $453M | 9.58 | 3.28% | 11.31% | 17.23% | 1.57% | |
| $24.69 | $1.69B | 16.33 | 7.08% | 5.58% | 20.22% | — |
Chemed Corporation (CHE) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Chemed Corporation (CHE) SEC filings — annual & quarterly reports (10-K, 10-Q)
Oct 27, 2026·SEC
Jul 28, 2026·SEC
May 19, 2026·SEC
Get notified when CHE posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Chemed Corporation (CHE) stock FAQ — growth, dividends, profitability & financials explained
Chemed Corporation (CHE) reported $2.66B in revenue over the trailing twelve months. Revenue was $2.53B in fiscal year 2025. That is 740% more than the $301.2M of fiscal year 1996.
Chemed Corporation (CHE) grew revenue by 5.2% over the trailing twelve months, compared with the twelve months before.
Yes. Chemed Corporation (CHE) earned $282.4M in net income over the trailing twelve months (a 10.6% net margin).
Yes. Chemed Corporation (CHE) pays a dividend that yields 0.40% at the current price, a small yield.
Chemed Corporation (CHE) had a return on equity (ROE) of 32.1% over the trailing twelve months. That is well above the market's typical 10-15%.
Chemed Corporation (CHE) generated $295.5M in free cash flow over the trailing twelve months.